Paratek Pharmaceuticals, Inc. (PRTK)
(Delayed Data from NSDQ)
$5.36 USD
+0.04 (0.75%)
Updated May 3, 2019 04:00 PM ET
After-Market: $5.35 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For PRTK
-
Paratek Pharmaceuticals (PRTK) Reports Q2 Loss, Tops Revenue Estimates
-
Paratek: Q2 Earnings Snapshot
-
Paratek Pharmaceuticals (PRTK) Reports Q1 Loss, Misses Revenue Estimates
-
Paratek: Q1 Earnings Snapshot
-
Paratek Pharmaceuticals (PRTK) Reports Q4 Loss, Tops Revenue Estimates
-
Paratek Pharmaceuticals (PRTK) Reports Q3 Loss, Lags Revenue Estimates
-
Paratek: Q3 Earnings Snapshot
-
Paratek: Q2 Earnings Snapshot
-
Paratek Pharmaceuticals (PRTK) Reports Q2 Loss, Tops Revenue Estimates
-
Paratek Pharmaceuticals (PRTK) Reports Q3 Loss, Tops Revenue Estimates
-
Earnings Preview: Paratek Pharmaceuticals (PRTK) Q3 Earnings Expected to Decline
-
Paratek Pharmaceuticals (PRTK) Q2 Earnings and Revenues Miss Estimates
-
Paratek Pharmaceuticals (PRTK) Earnings Expected to Grow: What to Know Ahead of Q2 Release
-
Paratek Pharmaceuticals (PRTK) Reports Q1 Loss, Misses Revenue Estimates
-
Paratek Pharmaceuticals (PRTK) Reports Q4 Loss, Misses Revenue Estimates
-
Paratek Pharmaceuticals (PRTK) Reports Q3 Loss, Tops Revenue Estimates
-
Paratek Pharmaceuticals (PRTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
-
Paratek Pharmaceuticals (PRTK) Reports Q2 Loss, Lags Revenue Estimates
-
Paratek Pharmaceuticals (PRTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
-
Will Paratek Pharmaceuticals (PRTK) Report Negative Q2 Earnings? What You Should Know
-
Paratek Pharmaceuticals (PRTK) Reports Q1 Loss, Tops Revenue Estimates
-
Paratek Pharmaceuticals (PRTK) Reports Q4 Loss, Tops Revenue Estimates
-
Paratek Pharmaceuticals (PRTK) Reports Q3 Loss, Tops Revenue Estimates
-
Analysts Estimate Paratek Pharmaceuticals (PRTK) to Report a Decline in Earnings: What to Look Out for
-
Earnings Preview: Paratek Pharmaceuticals (PRTK) Q3 Earnings Expected to Decline